• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of qualhcLink to Publisher's site
Qual Health Care. Jun 1993; 2(2): 91–95.
PMCID: PMC1055091

Use of laboratory testing for genital chlamydial infection in Norway.


OBJECTIVE--To assess the use of laboratory tests for genital chlamydial infection in Norway. DESIGN--Questionnaire survey of general practitioners' practice in chlamydial testing, retrospective survey of laboratory records, 1986-91, and prospective study of testing in one laboratory during four weeks. SETTING--All 18 microbiological laboratories in Norway (4.2 million population), including one serving all doctors in Vestfold county (0.2 million population). SUBJECTS--302 general practitioners. MAIN MEASURES--GPs' routine practice, methods used for testing, 1986-91, and sex specific and age group specific testing in 1991. RESULTS--201(69%) GPs replied to the questionnaire: 101(51%) would test all women younger than 25 years at routine pelvic examination, 107(54%) all girls at first pelvic examination, 131(66%) all pregnant women, and 106(54%) all men whose female partner had urogenital complaints. Nationwide in 1986, 122,000 tests were performed (2.9 per 100 population); 10% were positive and 51% were cell culture tests. In 1991, 341,000 tests were performed (8.0 per 100 population); 4.5% were positive and 15% were cell culture tests. 13,184 tests were performed in Vestfold in 1991 (6.6 per 100 population). The age group specific rates (per 100 population) among women were: age 15-19 years, 22.0(95% confidence interval 18.2 to 25.8); 20-24 years, 47.2(42.1 to 52.3); 25-29 years, 42.3(37.1 to 47.5); 30-34 years, 29.8(25.4 to 34.2); and 35-39 years, 12.5(9.5 to 15.5). CONCLUSIONS--GPs use liberal indications for testing. The dramatic increase in testing, especially by enzyme immunoassays, in populations with a low prevalence of infection results in low cost effectiveness and low predictive value of positive tests, which in women over 29 years is estimated as 17-36%. IMPLICATIONS--Doctors should be educated about the limitations of enzyme immunoassays in screening low prevalence populations, and laboratories should apply a confirmatory test to specimens testing positive with such assays.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (862K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cates W, Jr, Rolfs RT, Jr, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev. 1990;12:199–220. [PubMed]
  • Cates W, Jr, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 2):1771–1781. [PubMed]
  • Zimmerman HL, Potterat JJ, Dukes RL, Muth JB, Zimmerman HP, Fogle JS, Pratts CI. Epidemiologic differences between chlamydia and gonorrhea. Am J Public Health. 1990 Nov;80(11):1338–1342. [PMC free article] [PubMed]
  • Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA. 1986 Apr 4;255(13):1730–1734. [PubMed]
  • Kellogg JA. Clinical and laboratory considerations of culture vs antigen assays for detection of Chlamydia trachomatis from genital specimens. Arch Pathol Lab Med. 1989 May;113(5):453–460. [PubMed]
  • Chonmaitree T, Baldwin CD, Lucia HL. Role of the virology laboratory in diagnosis and management of patients with central nervous system disease. Clin Microbiol Rev. 1989 Jan;2(1):1–14. [PMC free article] [PubMed]
  • Taylor-Robinson D, Thomas BJ. Laboratory techniques for the diagnosis of chlamydial infections. Genitourin Med. 1991 Jun;67(3):256–266. [PMC free article] [PubMed]
  • Nordbø SA, Mehl A, Vik IS, Ragnhildstveit E. Diagnostikk av Chlamydia trachomatis--dyrking eller enzymimmunoassay? En norsk multisenterundersøkelse. Tidsskr Nor Laegeforen. 1991 Aug 20;111(19):2413–2416. [PubMed]
  • Aavitsland P. Survey of the treatment of Chlamydia trachomatis infection of the female genital tract. Acta Obstet Gynecol Scand. 1992 Jul;71(5):356–360. [PubMed]
  • Mowinckel R, Staurset JA, Holen P, Aavitsland P. Norske legers rutiner for smitteoppsporing ved genitale chlamydiainfeksjoner. En spørreundersøkelse. Tidsskr Nor Laegeforen. 1992 May 20;112(13):1729–1733. [PubMed]
  • Edwards PJ, Hall DM. Screening, ethics, and the law. BMJ. 1992 Aug 1;305(6848):267–268. [PMC free article] [PubMed]
  • Nettleman MD, Jones RB. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. JAMA. 1988 Jul 8;260(2):207–213. [PubMed]
  • Estany A, Todd M, Vasquez M, McLaren R. Early detection of genital chlamydial infection in women: an economic evaluation. Sex Transm Dis. 1989 Jan-Mar;16(1):21–27. [PubMed]
  • Phillips RS, Aronson MD, Taylor WC, Safran C. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med. 1987 Aug;107(2):188–194. [PubMed]
  • Buhaug H, Skjeldestad FE, Backe B, Dalen A. Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med Care. 1989 Aug;27(8):833–841. [PubMed]
  • Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA. 1986 Apr 4;255(13):1730–1734. [PubMed]
  • Johnson BA, Poses RM, Fortner CA, Meier FA, Dalton HP. Derivation and validation of a clinical diagnostic model for chlamydial cervical infection in university women. JAMA. 1990 Dec 26;264(24):3161–3165. [PubMed]
  • Mills RD, Young A, Cain K, Blair TM, Sitorius MA, Woods GL. Chlamydiazyme plus blocking assay to detect Chlamydia trachomatis in endocervical specimens. Am J Clin Pathol. 1992 Feb;97(2):209–212. [PubMed]

Articles from Quality in Health Care : QHC are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...